High CRP linked to cognitive problems among elderly Breast Cancer survivors Dr. Kamal Kant Kohli17 Oct 2022 8:00 PM ISTScientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment....
Regular aspirin use lowers risk of ovarian cancer development: Study Dr. Kamal Kant Kohli17 Oct 2022 7:30 PM ISTUSA: Despite the existence of the majority of other ovarian cancer risk factors, frequent aspirin use is linked to a decreased risk of ovarian cancer,...
Gilead Sciences Trodelvy under USFDA priority review for adult patients with pretreated metastatic breast cancer Ruchika Sharma14 Oct 2022 2:30 PM ISTTrodelvy (sacituzumab govitecan-hziy) is a first-in-class Trop-2 directed antibody-drug conjugate.
Medical Bulletin 1/October/2022 Isra Zaman1 Oct 2022 2:38 PM ISTHere are the top medical news for the day:Another possible monkey virus spillover threat for humansAn obscure family of viruses, already endemic in...
Link between inflammation and cognitive problems in older breast cancer survivors reaffirmed Isra Zaman1 Oct 2022 10:45 AM ISTScientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment....
Medical Bulletin 28/September/2022 Isra Zaman28 Sept 2022 6:00 PM ISTHere are the top medical news for the day:Ban of menthol cigarettes help smokers to quit, reaffirmed by new studyA new study concludes that the 2020...
Immunotherapy before targeted therapy significantly improves advanced melanoma survival Isra Zaman28 Sept 2022 9:45 AM ISTA clinical trial led by clinicians at Georgetown Lombardi Comprehensive Cancer Center showed a remarkable 20 percent advantage in the two-year overall...
Hormone lowering treatment linked to reduced recurrence of breast cancer in premenopausal women Jacinthlyn Sylvia27 Sept 2022 8:00 PM ISTA recent study published in the Journal of Clinical Oncology shows that in estrogen receptor-positive premenopausal individuals 2 years of adjuvant...
AstraZeneca Lynparza shows clinically meaningful survival benefit in 1st-line advanced ovarian cancer across two Phase III trials Ruchika Sharma11 Sept 2022 1:15 PM ISTOvarian cancer is one of the most common gynaecologic cancers, with a poor prognosis and a high mortality rate.
New cervicovaginal epigenetic test enables rapid noninvasive screening for endometrial Cancer: Study Dr. Kamal Kant Kohli30 Aug 2022 7:30 PM ISTSpain: Women experiencing signs of endometrial cancer can now be assessed with a noninvasive, credible test, which can help with early detection and...
Frequent Aspirin Use Shows Promise for Preventing Ovarian Cancer in Individuals at Higher Risk Dr. Kamal Kant Kohli29 July 2022 7:45 PM ISTFrequent aspirin use is linked with lower ovarian cancer risk in individuals with multiple risk factors, according to a new study published in the...
Oral paclitaxel with encequidar improves overall survival and progression-free survival in breast cancer Jacinthlyn Sylvia22 July 2022 7:45 PM ISTUSA: Compared to intravenous paclitaxel (IVpac), oral paclitaxel plus Encequidar (oPac + E) improved the confirmed tumor response while showing trends...
